FLG-AS1 rs12123821: Understanding Your Genetic Association
The genetic variant rs12123821 is an intergenic marker located on chromosome 1 within the epidermal differentiation complex. It is statistically associated with an increased risk for food allergy, atopic dermatitis, and asthma, primarily due to its linkage with loss-of-function mutations in the nearby filaggrin (FLG) gene.
What each genotype means
Typical baseline atopic risk
You carry two copies of the common A allele for this regulatory variant near the FLG gene cluster. Genome-wide association studies link this baseline genotype with typical population risk for atopic dermatitis, food allergy, and asthma. Because this variant exerts only modest regulatory effects, your overall allergic predisposition is influenced by many other genetic and environmental factors.
Carried by approximately 84% to 86% of individuals of European ancestry and is the predominant genotype worldwide.
Slightly increased atopic risk
You carry one copy of the minor G allele near the filaggrin locus. Research indicates that this genotype is modestly associated with an increased susceptibility to atopic traits, including eczema, asthma, and food allergy. However, evidence remains limited and statistical association does not mean you will develop an allergic condition.
Carried by approximately 14% to 15% of individuals of European ancestry and is less common in non-European populations.
Modestly increased atopic risk
You carry two copies of the minor G risk allele for this filaggrin-associated regulatory marker. Published association studies link this genotype with a modest elevation in statistical risk for allergic conditions such as atopic dermatitis and food allergies. The observed clinical impact of this noncoding variant remains limited compared to classic filaggrin loss-of-function mutations.
Carried by fewer than 1% of individuals of European descent and is very rare globally.
What is rs12123821?
The variant rs12123821 is a single nucleotide polymorphism (SNP) located on the long arm of chromosome 1 (1q21.3). It sits within an intergenic region—a stretch of DNA between genes—that is part of the epidermal differentiation complex (EDC). This complex is a cluster of genes essential for the development and maintenance of the skin barrier. In genetic research, rs12123821 is frequently identified in genome-wide association studies (GWAS) as a marker for skin and immune-related conditions. It is important to note that while this SNP is the marker identified by statistical analysis, it is not necessarily the direct cause of the conditions associated with it. Instead, it often serves as a 'tag' or proxy for other functional genetic changes nearby, specifically those that disrupt the normal function of the filaggrin gene.
The Role of the Filaggrin (FLG) Gene
The filaggrin (FLG) gene provides instructions for making a protein that is vital for the structural integrity of the skin. Filaggrin acts like a glue that helps hold skin cells together, creating a robust barrier that keeps moisture in and environmental irritants, allergens, and pathogens out. When the FLG gene contains loss-of-function (LoF) mutations, the body produces little to no functional filaggrin protein. This deficiency leads to a compromised skin barrier, which is a hallmark of atopic dermatitis (eczema). Because the skin barrier is weakened, it may allow allergens to enter the body more easily, potentially triggering immune responses that lead to food allergies or asthma. Research has shown that the association between rs12123821 and these conditions is largely explained by its linkage to these specific FLG mutations.
Research and Evidence Strength
The evidence linking rs12123821 to food allergy, asthma, and atopic dermatitis is considered robust in terms of statistical association, but it is important to understand the context. Large-scale studies have consistently shown that this variant is significantly associated with these traits. However, follow-up analyses have demonstrated that the association signal at this location is primarily driven by linkage disequilibrium (LD) with known FLG loss-of-function mutations, such as c.2282del4 and p.R501X. This means that rs12123821 is essentially 'hitchhiking' on the same chromosome as these functional mutations. While the association is strong, it is not a direct diagnostic tool. Furthermore, the risk for asthma associated with these variants is often observed only in individuals who also have atopic dermatitis, suggesting that the genetic risk is tied to the broader spectrum of atopic disease rather than asthma in isolation.
Population Frequency
The frequency of the rs12123821 variant varies significantly across different ancestral populations. In European populations, the minor allele frequency is approximately 0.08. It is well-documented that the prevalence and specific types of FLG mutations differ by ancestry; for example, certain mutations common in European populations are rare or absent in other groups. Conversely, other populations may carry different, ancestry-specific variants that affect the same gene. Because of these differences, the statistical association observed in one population may not be directly applicable to another. Researchers are currently working to expand genomic studies to more diverse groups to better understand how these variants influence health across different genetic backgrounds.
What This Information Means for You
If you have received information about your status for rs12123821, it is important to view it as a piece of statistical data rather than a medical diagnosis. This variant is a marker for a complex genetic landscape involving the skin barrier, and having a specific genotype does not guarantee that you will develop food allergies, asthma, or eczema. These conditions are multifactorial, meaning they are influenced by a combination of genetics, environmental exposures, and other lifestyle factors. You cannot use this information to diagnose yourself or predict your health outcomes with certainty. If you have concerns about allergies or skin health, the most effective approach is to consult with a healthcare professional, such as an allergist or dermatologist. They can evaluate your symptoms, medical history, and environmental factors to provide appropriate guidance and care.
How common is this variant?
The minor allele frequency for rs12123821 is approximately 0.08 in European populations, though frequencies and associated mutation patterns vary significantly across different global ancestries.
Frequently asked questions
Does having the rs12123821 variant mean I have a food allergy?
No. This variant is a statistical marker associated with an increased risk of developing food allergies, but it is not a diagnostic test. Many people with this variant do not have food allergies, and many people with food allergies do not carry this specific variant.
Is rs12123821 the same as a filaggrin mutation?
No, they are different. rs12123821 is a marker located near the filaggrin (FLG) gene. It is often found in the same individuals who carry functional filaggrin mutations, which is why they appear linked in research studies.
Can I use this information to change my diet?
You should not change your diet based on this genetic information. Dietary decisions should be made in consultation with a doctor or a registered dietitian, especially if you suspect you have a food allergy.
Why is this variant linked to both asthma and eczema?
These conditions are part of the 'atopic march,' where a compromised skin barrier (often caused by filaggrin mutations) can lead to increased allergen exposure. This exposure can trigger immune responses that manifest as eczema, and subsequently, asthma or food allergies in some individuals.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12123821?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29